Auvin, Stéphane http://orcid.org/0000-0003-3874-9749
Avbersek, Andreja
Bast, Thomas
Chiron, Catherine
Guerrini, Renzo
Kaminski, Rafal M.
Lagae, Lieven
Muglia, Pierandrea
Cross, J. Helen
Article History
First Online: 16 November 2019
Compliance with Ethical Standards
:
: UCB Pharma has supported the meeting of the experts in June 2017.
: Stéphane Auvin has served as consultant or received honoraria for lectures from Advicenne Pharma, Biocodex, Eisai, GW Pharma, Novartis, Nutricia, Shire, UCB Pharma, Ultragenyx, Zogenix. He has been investigator for clinical trials for Advicenne Pharma, Eisai, UCB Pharma and Zogenix. Andreja Avbersek and Pierandrea Muglia are full time employees of UCB Pharma. Rafal Kaminski was an employee of UCB Pharma during the time this analysis was completed. Thomas Bast has participated as a clinical investigator or DMC member for Eisai, Marinus, Novartis, Nutricia and UCB Pharma. He has been a member of advisory boards and/or speaker for BIAL, Biocodex, Eisai, Desitin Arzneimittel GmbH, GW Pharmaceuticals, Shire, UCB Pharma and Zogenix. Catherine Chiron has been member of advisory boards and/or speaker for BIAL, Biocodex, UCB Pharma and Zogenix. J. Helen Cross has participated as a clinical investigator for GW Pharma, Marinus Pharmaceuticals, Vitaflo and Zogenyx. She has been a member of advisory boards and speaker for Eisai, GW Pharma, Nutricia and Zogenix. All renumeration has been made to her department. Lieven Lagae is a member of an advisory board and invited speaker for Epihunter, Livanova, UCB Pharma, Shire and Zogenix. Renzo Guerrini received honoraria from Biocodex, Eisai Inc., UCB Pharma, ValueBox, ViroPharma, Zogenyx and research support from the Italian Ministry of Health, the European Community Sixth and Seventh Framework Thematic Priority Health, the Italian Ministry of Education, University and Research, the Tuscany Region, the Telethon Foundation, the Mariani Foundation, and The Italian Association for Epilepsy.